About Kekule Pharma Limited
Data last updated:
Kekule Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 29 November 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG1984PLC005145. Its GSTIN is 36AABCK3469K1Z8 (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹19 Cr. It is led by directors including Kudaravalli Sridhar (Managing Director) and Kudaravalli Durgarani (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H. No. 8 – 3 – 680 Opp. Vishal Towers Lic Colony Yellareddy Guda, Hyderabad, Telangana, India – 500073.
As per the financials filed for FY 2024, the company reported a revenue of ₹144.48 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹3.44 Cr (net margin 2.4%) and EBITDA of ₹11.28 Cr (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The company has about 158 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kekule Pharma. As per MCA filings, the company has open charges of ₹107.64 Cr and satisfied charges of ₹109.15 Cr on record. Court records list 13 cases involving the company, including 9 filed by the company and 4 filed against it; 1 case is pending. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.9 Cr; the latest was in February 2014. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 323 overdue payments to 80 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kekulepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressH. No. 8 – 3 – 680 Opp. Vishal Towers Lic Colony Yellareddy Guda, Hyderabad, Telangana, India – 500073
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kekule Pharma Limited
The main business activity of Kekule Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kekule Pharma Limited FY 2024 filings available
Kekule Pharma Limited reported revenue of ₹144.48 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Kekule Pharma Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 5% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kekule Pharma Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹144.48 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.28 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.44 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kekule Pharma Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kekule Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Kekule Pharma Limited
Kekule Pharma Limited is audited by M N Rao Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M N Rao Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Kekule Pharma Limited
Kekule Pharma Limited currently reports 5 directors and 1 key managerial person. 14 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nadella Madhava Rao Also directs: Madhava Hi-Tech Cold Storage Private Limited | Director | 03 Mar 2017 | 9 Years 7 Months | Current |
| Jaswanthi Chittabathini Also directs: Ricer Research Private Limited | Director | 13 Feb 2024 | 2 Years 7 Months | Current |
| Kudaravalli Durgarani Also directs: Premier Klenz Private Limited, Kekule Pharmaceuticals (A.P) Limited, Dura Estates Private Limited and 1 more | Whole-Time Director | 15 Jun 2001 | 25 Years 3 Months | Current |
| Srilakshmi Kudaravalli | Cfo | 03 Mar 2017 | 9 Years 7 Months | Current |
| Kudaravalli Raja Rao Also directs: Premier Klenz Private Limited, Kekule Pharmaceuticals (A.P) Limited, Alpha Energy Systems Limited and 3 more | Whole-Time Director | 26 May 2004 | 22 Years 4 Months | Current |
| Kudaravalli Sridhar Also directs: Alpha Energy Systems Limited, Kekule Life Sciences Limited | Managing Director | 20 Feb 1998 | 28 Years 7 Months | Current |
Ownership and Shareholding of Kekule Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kekule Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2023 | Others | ₹38.69 Cr | Open |
| 28 Apr 2022 | Others | ₹58.95 Cr | Open |
| 30 Jul 2020 | Others | ₹10 Cr | Open |
| 28 Mar 2022 | Others | ₹2.6 Cr | Satisfied |
| 09 Sep 2020 | Others | ₹2.77 Cr | Satisfied |
Total charge records: 25 View all charges
Deals & Funding of Kekule Pharma Limited
Kekule Pharma Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.9 Cr; the latest was in February 2014.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2014 | Funding round | ₹1.4 Cr | Investors: 2 individuals |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2012 | Funding round | ₹3 Cr | Investors: 4 individuals |
| Sep 2007 | Secondary share transfer | Undisclosed | Buyer: Premier Klenz Private Limited , 3 individuals Seller: Premier Industrial Equipments Private Limited, an individual |
| Mar 2006 | Funding round | ₹2.5 Cr | Investors: Premier Industrial Equipments Private Limited, 3 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Kekule Pharma Limited
Kekule Pharma Limited has 13 court cases on record: 9 filed by Kekule Pharma, 4 filed against it. 1 case is pending and 12 are disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 3 | 1 |
| High courts | 5 | 1 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (CC.NI) | Filed by the company against Qualitek Pharma Private Limited | Pending |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against Qualitek Pharma Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Qualitek Pharma Private Limited | Disposed |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Andhra Pradesh | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against Telangana Electricity Regulatory Commission | Disposed |
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Kekule Pharma Limited
Kekule Pharma Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 323 overdue payments to 80 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 80)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sayar Chemical Industries | •••• | •••• | •••• |
| Sanchem Sophin Private Limited | •••• | •••• | •••• |
| Yogi Dye Chem Industries | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Unique Control System | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Kekule Pharma Limited
Kekule Pharma operates one associated brand: Kekule Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical company manufacturing high-quality active pharmaceutical ingredients and intermediates. | kekulepharma.com |
Employees and EPFO Compliance at Kekule Pharma Limited
Kekule Pharma Limited has a workforce of 158 employees as of Oct 13, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Kekule Pharma Limited
Kekule Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231TG1984PLC005145, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG1984PLC005145 | Current |
| U01119AP2006PTC048851 | Previous |
| U24231AP1984PLC005145 | Previous |
Recent Activity on Kekule Pharma Limited
Kekule Pharma Limited has 19 board changes on record since 1998: 7 appointments and 12 cessations. The latest: Jaswanthi Chittabathini ceased to be Additional Director on 07 Mar 2024.
69 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kekule Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kekule Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kekule Pharma Limited
Kekule Pharma has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCK3469K1Z8 | Telangana | Active | 01 Jul 2017 |
| 37AABCK3469K3Z4 | Andhra Pradesh | Active | 22 Jun 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kekule Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kekule Pharma Limited
Kekule Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 29 November 1984 (42+ years old) and is registered under CIN U24231TG1984PLC005145.
Kekule Pharma reported revenue of ₹144.48 Cr for FY 2024 (up 5% YoY).
Kekule Pharma has 6 current directors and KMP:
- Kudaravalli Sridhar - Managing Director
- Kudaravalli Durgarani - Whole-Time Director
- Kudaravalli Raja Rao - Whole-Time Director
- Nadella Madhava Rao - Director
- Jaswanthi Chittabathini - Director
- Srilakshmi Kudaravalli - Cfo
Kekule Pharma reported a net profit of ₹3.44 Cr (net margin 2.4%) and EBITDA of ₹11.28 Cr (EBITDA margin 7.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kekule Pharma is 3% over three years and 1% over five years. In the latest year (FY 2024) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kekule Pharma is 36AABCK3469K1Z8, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 37AABCK3469K3Z4 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Kekule Pharma is U24231TG1984PLC005145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kekule Pharma has 13 court cases on record: 9 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.
Kekule Pharma was incorporated on 29 November 1984, making it 42+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kekule Pharma has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.9 Cr; the latest was in February 2014.
Jaswanthi Chittabathini ceased to be Additional Director on 07 Mar 2024. Jaswanthi Chittabathini was appointed as Director on 13 Feb 2024. Kudaravalli Raja Rao ceased to be Managing Director on 16 Feb 2022. Kekule Pharma has 19 board changes on record in total.